You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

  • Technology appraisal guidance
  • Reference number: TA195
  • Published:  25 August 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: professional and patient groups

  • Arthritis Care

  • Arthritis and Musculoskeletal Alliance

  • Arthritis Research

  • British Health Professionals in Rheumatology

  • British Society for Rheumatology

  • National Rheumatoid Arthritis Society

  • National Rheumatoid Arthritis Society - appendix 1

  • Royal College of Nursing

  • Royal College of Physicians

  • Royal College of Pathologists

  • Department of Health

  • NHS Quality Improvement Scotland

  • UCB


This page was last updated: 24 June 2010

Back to top